Within the mental, neurological, and substance use disorder group, particular disorders make a disproportionate contribution to the burden; for these, the need for cost-effective interventions is highest. Depressive and anxiety disorders are very prevalent and are significant contributors to the burden. Treatment rates for these disorders are low in most countries, as they are for epilepsy, migraine, alcohol, and opioid dependence, the other large contributors to disease burden.
